Publications

Prescription Drug Freight Fraud, June 2026 report Over the past year, our freight fraud investigations have documented a rapidly evolving pipeline of pharmaceutical imports tied to increasing demand for weight loss and wellness drugs. In previous reports, we identified kilogram-scale shipments of semaglutide and tirzepatide entering the United States from ...

Prescription drug freight fraud, April 2026 Over the last six months, freight fraud involving GLP-1 drugs was persistent and adaptive. Semaglutide and tirzepatide shippers evolved tactics to obscure origins, contents, and manufacturing sources. We observed familiar risks, unregistered facilities, residential "manufacturers," and expanding code fraud.   Read the report and ...

What is master carton smuggling? In March, customs officers in Cincinnati announced that they had intercepted around 5,000 individual shipments of GLP-1s and other peptides packaged inside more than 300 "master cartons" with deceptive manifests meant to slip by inspections unnoticed. Curious how this smuggling scheme works? Read on, and ...

Using pharmacy-to-pharmacy marketplaces? Read this Suspicious Sales Surveillance Report March 24, 2026 Online pharmacy-to-pharmacy marketplaces help pharmacies with inventory management, but they also carry a higher risk of being exploited by criminals selling black market medicines that are a threat to American patients. Because of that, pharmacies who use these ...

Update on drug importation, February 2026 For over 25 years, well-meaning advocates have proposed importing unauthenticated medicine from foreign countries' drug supplies to lower prices for Americans. Past efforts didn't pay off financially and raised public health risks, but legislatures continue to consider state importation schemes while individual employers are ...

Prescription drug freight fraud report, January 2026 In November and December 2025, thousands of shipments of drugs that have been popularized by social media were imported into the United States, along with rivaroxaban (Xarelto) and antibiotics. They were imported into the country with a wide range of product code classifications, ...

Pill press update: July 2025 through January 2026 February 10, 2026 Policymakers became generally aware of pill presses with the rise of the opioid crisis, when drug traffickers began selling counterfeit prescription pills made with fentanyl, with catastrophic results. Illegal pill presses and molds continue to create fake pills that ...

Employers, do you know how much you're paying PBMs? Pharmacy benefit managers (PBM) tactics have increased costs for patients and healthcare purchasers all while driving community pharmacies out of business and failing to deliver on their promise to lower medication costs. Learn more about these tactics and what states are ...

Why are price caps a bad solution for medicine affordability? Americans need affordable access to medicines, but upper payment limits (UPLs) set by prescription drug affordability boards and Medicare Maximum Fair Prices (MFPs) are not viable solutions. In our complex drug supply chain, these price caps could bankrupt pharmacies and ...

Prescription Drug Freight Fraud Report, November 2025 Our latest analysis of FDA import records shows a continuation of the troubling patterns we've been documenting since February. From September 1 to October 31, 2025, large-scale freight fraud involving GLP-1s, oncology drugs, and other high-demand pharmaceuticals continued unabated, and in several areas ...